Literature DB >> 12409265

An angiogenic, endothelial-cell-targeted polymeric gene carrier.

Wonhee Suh1, Sang-Oh Han, Lei Yu, Sung Wan Kim.   

Abstract

Targeting is one of the primary considerations in designing a specific and efficient gene delivery system. Here, an angiogenic endothelial cell-targeted polymeric gene delivery carrier was developed by conjugating an alpha(v)beta3/alpha(v)beta5 integrin-binding RGD peptide, ACDCRGDCFC, into the cationic polymer polyethyleneimine (PEI) via a hydrophilic poly(ethylene glycol) (PEG) spacer. The incorporation of PEG into PEI improved the poor physicochemical properties of PEI-DNA complexes. At a neutral charge ratio, DNA complexes with PEI were polydisperse and substantially aggregated, whereas DNA complexes with PEI-g-1PEG-RGD were homogeneous with 100-200 nm effective diameter. Their surface charge was also significantly reduced due to the charge shielding effect of PEG. However, the extensive grafting of PEI with PEG was shown to inhibit the DNA condensation process, significantly decreasing transfection efficiency. In in vitro transfection experiments with angiogenic endothelial cells, PEI-g-1PEG-RGD showed an approximately fivefold increase in transfection efficiency over PEI, due to an integrin-mediated internalization pathway. PEI-g-1PEG-RGD also exhibited high specificity to angiogenic endothelial cells compared with normal endothelial cells, which was confirmed by in vitro transfection experiments with non-targeting PEI-g-1PEG-RAE in angiostatic endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409265

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  28 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

3.  A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.

Authors:  Mark C Butler; Patrick N Itotia; Jack M Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

4.  Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice.

Authors:  Yuanxiang Lao; Yanyan Li; Ping Zhang; Qianqian Shao; Weiran Lin; Bintao Qiu; Yongzhuang Lv; Lichun Tang; Shishuai Su; Hongyu Zhang; Chunyan Tian; Aihua Sun; Handong Wei; Pumin Zhang; Yan Wu; Ying Jiang; Fuchu He
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

Review 5.  Encapsulation of nucleic acids and opportunities for cancer treatment.

Authors:  Lisa Brannon-Peppas; Bilal Ghosn; Krishnendu Roy; Kenneth Cornetta
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

Review 6.  Polyethylene glycol-conjugated copolymers for plasmid DNA delivery.

Authors:  Minhyung Lee; Sung Wan Kim
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

7.  Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.

Authors:  Ashutosh Barve; Akshay Jain; Hao Liu; Zhen Zhao; Kun Cheng
Journal:  Acta Biomater       Date:  2020-06-18       Impact factor: 8.947

8.  Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.

Authors:  Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

Review 9.  Bioreducible polymers for therapeutic gene delivery.

Authors:  Young Sook Lee; Sung Wan Kim
Journal:  J Control Release       Date:  2014-04-16       Impact factor: 9.776

10.  Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.

Authors:  Qing-Hui Zhou; Ye-Zi You; Chao Wu; Yi Huang; David Oupický
Journal:  J Drug Target       Date:  2009-06       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.